Ticker Details
IQVIA Holdings Inc. IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
IPO Date:	May 9, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$28.37B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.20 | 1.21%
Avg Daily Range (30 D):	$2.85 | 1.67%
Avg Daily Range (90 D):	$3.33 | 1.69%

Institutional Daily Volume
Avg Daily Volume:	1.05M
Avg Daily Volume (30 D):	1.35M
Avg Daily Volume (90 D):	1.47M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	9,136
Avg Institutional Trade:	$11.84M
Avg Institutional Trade (30 D):	$16.51M
Avg Institutional Trade (90 D):	$16.68M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$30.4M
Avg Closing Trade (30 D):	$50.66M
Avg Closing Trade (90 D):	$56.49M
Avg Closing Volume:	167.08K

News

Feb 25, 2026 @ 2:06 PM Charles River Labs Breaks The Mold, Announces Bold... Source: Vandana Singh

Feb 25, 2026 @ 9:00 AM Pharmacovigilance Market Size to Reach USD 24.69 B... Source: Sns Insider

Feb 18, 2026 @ 3:00 PM Clinical Trials Support Software Solutions in a $3... Source: Towards Healthcare

Feb 5, 2026 @ 4:00 PM Real-World Data on Healthcare Technology Adoption:... Source: Towards Healthcare

Jan 19, 2026 @ 3:00 PM Why Clinical Data Analytics Is Becoming One of Hea... Source: Towards Healthcare

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$7.91	$3.01	$7.91
Diluted EPS	$7.84	$2.98	$7.84
Revenue	$16.31B	$4.36B	$16.31B
Gross Profit
Net Income / Loss	$1.36B	$514M	$1.36B
Operating Income / Loss	$2.18B	$627M	$2.18B
Cost of Revenue
Net Cash Flow	$278M	$166M	$278M
PE Ratio	21.34